Sourasky Medical Center (Ichilov)
Sourasky Medical Center (Ichilov)
Israel, Tel Aviv
Pelles Sharon
23 years of experience
Clinic is certified :
Rectal cancer treatment cost in Israel typically runs between $22,500 and $35,000 for advanced surgical interventions. A standard diagnostic workup, including transrectal ultrasound, ranges from $200 to $500. Total expenses depend on the cancer stage, the use of robotic technology, and the hospital's status. Patients often see 20-40% savings compared to the US. Top treatment centers are located in Tel Aviv, Jerusalem, and Haifa.
Typical Rectal Cancer Treatment Costs in Israel
Bookimed Expert Insight: Patients seeking high-precision surgery should prioritize centers with robotic capabilities. Sourasky Medical Center (Ichilov) reports a 90% oncology success rate and utilizes AI-driven technologies. For complex cases involving peritoneal spread, the HIPEC expertise at Ichilov provides multidisciplinary value. Private options like Assuta Medical Center offer maximum patient control over surgeon selection. Jerusalem’s Hadassah Medical Center remains a premier choice for specialized gastrointestinal radiation therapy.
| Israel | Turkey | Austria | |
| Rectal resection | from $24,500 | from $10,250 | from $21,000 |
| NanoKnife | from $18,500 | from $9,500 | from $25,000 |
| Hyperthermic Intraperitoneal Chemotherapy (HIPEC) | from $61,200 | from $22,500 | from $40,000 |
| Gastric polyps removal | from $2,200 | from $990 | from $5,000 |
| Da Vinci Robotic System | from $22,500 | from $9,500 | from $22,000 |
Dr. Sharon Peles leads the digestive tract tumors institute at Sourasky Medical Center, specializing in systemic treatments for rectal cancer.
Professor Merimsky leads the bone and soft tissue tumor department at Sourasky Medical Center, specializing in tailored oncology treatments.
Dr. Einat Shacham‑Shmueli is a senior medical oncologist at the Gastrointestinal Clinic, Cancer Center, Sheba Medical Center. She treats cancers of the colon, stomach, and pancreas. She also manages metastatic disease. She uses precision diagnostics and biomarkers, systemic therapies, and radiotherapy. Care is provided within a multidisciplinary team.
She has authored more than 25 peer‑reviewed papers on GI oncology, tumor biology, and new treatments. Her work includes studies on stenting for malignant colonic obstruction. She serves as an investigator in international programs, including the NCI, the Radiation Therapy Oncology Group, and the Cancer Therapy Evaluation Program.
Education: MD, Tel Aviv University. Oncology residency, Tel Aviv Sourasky Medical Center. Advanced training in GI oncology, UCSF. Accreditations: Board certified in Oncology and Gastroenterology. Member, Israel Society of Oncology and Radiotherapy.
Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.
He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.
He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.